Event Details

This document is a page from a confidential financial report or presentation, numbered page 30, bearing a House Oversight Bates stamp. It analyzes 'Biopharma IPO Trends' from 2004 to Q1 2014, showing a significant spike in capital raised and number of IPOs in 2013 and early 2014. The text attributes this growth to the JOBS Act and 'testing the waters meetings,' suggesting a strong opportunity for investors in the healthcare technology sector.